重庆招聘

工作职责:

1. 肿瘤相关的NGS数据分析
2. 独立完成基于NGS技术的临床研究课题总结与汇报
3. 基因突变数据库使用与数据挖掘

任职要求:

1. 硕士/博士学历；
2. 生物信息专业；
3. 超强的学习能力以及逻辑思维；
4. 热爱科研分析与数据挖掘工作
5. 具备独立完成研究课题的能力，有独立分析NGS项目的经验
6. 有统计学基础，精通R语言的统计分析及做图；
7. 熟悉Linux，熟练掌握perl、Python、C、C++等至少一门编程语言;
8. 对NGS实验技术和数据分析方法有一定了解，熟悉常用生物信息学分析软件（如bwa, varscan等）;
9. 善于沟通，良好学习态度和工作责任感，良好的学习和逻辑分析能力；
10. 勤奋认真，团队合作。

关于燃石医学
燃石医学（纳斯达克代码：BNR）成立于2014年，公司使命为“用科学守护生命之光”，专注于为肿瘤精准医疗提供具有临床价值的二代基因测序（NGS）。公司业务及研发方向主要覆盖：1）基于NGS的肿瘤患病人群检测，6年间，燃石累计检测样本超过18.5万例，在中国市场份额领跑行业；2）基于NGS的癌症早检，目前已经进入临床验证阶段。
燃石医学于2018年7月率先获国家药品监督管理局（NMPA）颁发的中国肿瘤NGS检测试剂盒，在体外诊断领域具有里程碑式意义。实验室获得广东省临检中心颁发的 “高通量测序实验室”技术审核，以及得美国CLIA和CAP实验室质量体系资质认证。公司将继续致力于开发创新可靠的NGS检测产品，推动肿瘤精准医疗领域的发展。

About Burning Rock
Burning Rock Biotech Limited (NASDAQ: BNR), whose mission is to Guard Life via Science, focuses on the application of next generation sequencing (NGS) technology in the field of precision oncology. Its business consists of i) NGS-based therapy selection testing for late-stage cancer patients, with the leading market share in China and over 185,000 tissue and liquid-based tests completed cumulatively, and ii) NGS-based cancer early detection, which has moved beyond proof-of-concept R&D into the clinical validation stage.
In July 2018, Burning Rock received the first approval for a tumor NGS kit by the National Medical Products Administration (NMPA), which is a significant milestone in the field of in vitro diagnosis in China. Burning Rock’s laboratory has obtained the technical certification of “High-throughput sequencing laboratory” issued by Guangdong Center for Clinical Laboratory, and the CLIA and CAP laboratory quality system certification. The company continues to be committed to the development of innovative and reliable NGS testing products and promoting the development of precision medicine in oncology.